[Buruli ulcer in Togo: 21 cases].
Songné
B
B
Abété
B
B
Scotté
M
M
Tignokpa
N
N
Valenti
P
P
Tchangaï-Walla
K L
KL
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D017291:Clarithromycin / Q000008:administration & dosage; D003475:Curettage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D019911:Mycobacterium ulcerans; D012293:Rifampin / Q000008:administration & dosage; D016038:Skin Transplantation; D013997:Time Factors; D014037:Togo / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D004977:Ethambutol; D017291:Clarithromycin; D012293:Rifampin